BioXcel Therapeutics, Inc. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • BioXcel Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -134 %, a 27.2% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2023 was -145 %, a 98.8% decline from 2022.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2022 was -72.9 %, a 67.3% decline from 2021.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2021 was -43.5 %, a 18.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -145 -72 -98.8% Jan 1, 2023 Dec 31, 2023
2022 -72.9 -29.3 -67.3% Jan 1, 2022 Dec 31, 2022
2021 -43.5 +9.9 +18.5% Jan 1, 2021 Dec 31, 2021
2020 -53.5 +31.8 +37.3% Jan 1, 2020 Dec 31, 2020
2019 -85.3 -46.5 -120% Jan 1, 2019 Dec 31, 2019
2018 -38.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.